SCHEMBL31240513

SCHEMBL31240513

Nc1n[nH]c2ccc(-c3ccnc(NCCc4cccnc4)c3)cc12

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.50
▸ JAK2 O60674 3/20 0.49
▸ LRRK2 Q5S007 1/20 0.43
▸ DYRK1A Q13627 13/20 0.42
▸ CLK2 P49760 4/20 0.42
▸ CLK1 P49759 2/20 0.42
▸ CLK4 Q9HAZ1 2/20 0.42
▸ DYRK1B Q9Y463 2/20 0.42
▸ CDK2 P24941 2/20 0.42
▸ CDC7 O00311 1/20 0.42
▸ CCNE1 P24864 1/20 0.42
▸ DBF4 Q9UBU7 1/20 0.42
▸ CLK3 P49761 3/20 0.41
▸ WNT1 P04628 7/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240716 0.89 JAK2 (0.54) PIM1JAK2LRRK2DYRK1ACLK2
SCHEMBL31240406 0.87 JAK2 (0.60) PIM1JAK2LRRK2DYRK1ACLK2
SCHEMBL31240428 0.84 JAK2 (0.57) JAK2LRRK2DYRK1ACDK2CDC7
SCHEMBL31240447 0.83 JAK2 (0.48) JAK2LRRK2DYRK1ACLK2CLK4
SCHEMBL31240512 0.83 JAK2 (0.52) PIM1JAK2LRRK2DYRK1ACLK2
SCHEMBL31240674 0.83 JAK2 (0.48) PIM1JAK2LRRK2DYRK1ACLK2
SCHEMBL31240368 0.83 JAK2 (0.48) JAK2LRRK2DYRK1ACLK2CLK4
SCHEMBL31240411 0.81 CDC7 (0.58) PIM1JAK2LRRK2DYRK1ACLK2
SCHEMBL31240309 0.81 CYP1A2 (0.50) PIM1JAK2LRRK2DYRK1ACLK2
SCHEMBL31240555 0.80 JAK2 (0.55) JAK2LRRK2DYRK1ACLK2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback